Global: Early-stage healthcare funding slows for Thanksgiving holidays

Early-stage funding for healthcare companies was slow last week, possibly a reflection of the Thanksgiving holidays in the US. Shanghai-based ophthalmic biotechnology company Eluminex Biosciences has completed a US$50m Series A round of funding. It was co-led by Lilly Asia Ventures, GL Ventures – the venture capital arm of Hillhouse Capital – and Quan Capital….

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »